Uncategorized
Regeneron reports $999 million in total revenue in second quarter
Regeneron reported $999 million in total revenue in the second quarter, a 50% increase compared with $666 million in the same quarter of 2014, according to a press release. Net sales for Eylea (aflibercept) in the U.S. were reported at $655 million, a 58% increase compared with $415 million in the same quarter of 2014. Net sales for Eylea outside of the U.S. were reported at $338 million compared with $247 million in the same quarter of 2014.